We conduct financial and operational projects for small to mid-sized biotech and biopharma companies.

Due-Diligence

• Post-M&A due diligence: Evaluating the operational and financial health of acquired companies to ensure smooth integration.
• Investor-oriented evaluations: Reviewing accounting practices, ERP systems, and financial structures to meet investor expectations for compliance and scalability.
• ERP audit success: Performing evaluations to ensure GMP compliance and robust financial reporting processes.

These evaluations are rooted in a meticulous review of systems, financials, and operational efficiencies to improve transparency and decision-making.

Innovation Projects

We support innovation projects that focus on operational excellence and technological transitions:

• ERP Implementation: rollout of ERPs to streamline financial, supply chain, quality and manufacturing processes for life sciences companies.
• Digital Transformation: facilitating the transition of outdated financial and operational systems to modern, automated platforms that enable real-time reporting and decision-making.
• Cross-Border Innovation Support: Assisting biotech start-ups in the USA and Europe with scalable systems that meet regulatory and commercialisation demands, ensuring they are prepared for innovation-driven growth.

For companies in late-phase R&D (Phases 2/3), I have designed financial structures to support clinical-to-commercial transitions, a critical innovation milestone.

Experience in life sciences

• Scaling Operations: Supporting USA-based biotech firms in expanding operations to Europe for regulatory compliance and market entry.
• Supply Chain Optimization: Implementing ERP systems to improve industrial supply chain processes, ensuring GMP compliance and efficient inventory management.
• Reorganization and Integration: Leading post-acquisition integrations to align operational processes with the parent organization, focusing on efficiency and compliance.